CN103768300A - Traditional Chinese medicinal composition for treating intestinal cancer - Google Patents
Traditional Chinese medicinal composition for treating intestinal cancer Download PDFInfo
- Publication number
- CN103768300A CN103768300A CN201410012560.9A CN201410012560A CN103768300A CN 103768300 A CN103768300 A CN 103768300A CN 201410012560 A CN201410012560 A CN 201410012560A CN 103768300 A CN103768300 A CN 103768300A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicinal
- herba
- caulis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicinal preparations, and particularly relates to a traditional Chinese medicinal composition for treating intestinal cancer, which comprises the following components in parts by weight: 5-10 parts of Calculus Equi, 20-30 parts of Peristrophe japonica, 20-30 parts of Sargentodoxa cuneata stem, 20-30 parts of Menispermum dauricum rhizome, 20-30 parts of Saxifraga stolonifera, 20-30 parts of Solanum dulcamara, 10-20 parts of Tripterygium wilfordii, 10-20 parts of Gardenia jasminoides fruit, 10-20 parts of Rhizoma Arisaematis, 5-15 parts of Perilla frutescens stem, 5-15 parts of Acanthopanax senticosus, 5-15 parts of Poria cocos (Poria Alba), and 10 parts of Radix Glycyrrhizae. The traditional Chinese medicinal composition of the invention is prepared in accordance with the theory of traditional Chinese medicine, has effects of clearing away heat and toxic materials, relieving swelling and pain, regulating the flow of qi and strengthening the spleen, and has the advantages of traditional Chinese medicinal preparation, low toxic and adverse side effects, low cost and treatment of both symptoms and root causes.
Description
Technical field
The present invention relates to field of traditional Chinese, particularly a kind of Chinese medicine composition for the treatment of intestinal cancer.
Background technology
Colorectal cancer is common malignant tumor of digestive tract.The traditional Chinese medical science there is no ancient times to be deeply familiar with the system of colorectal cancer, according to the clinical manifestation of colorectal cancer different phase and evolution process, the record that has a large amount of similar primary disease to describe in TCM Document, content sporadically appears in the table of contents such as " hemorrhoidal hamorrhage ", " intestinal gill fungus ", " anorectal carcinoma ", " gathering ", " dysentery ", " intestinal knot ", has accumulated rich experience.As an important component part in colorectal cancer Comprehensive Treatment system, TCM Therapy is widely used in each stage of colorectal cancer, and curative effect obtains the approval of academia.
Determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs or differential diagnosis of diseases are the basic principles of Chinese medicine colorectal cancer with dialectical combining, there is distinct " individuation " characteristic, Chinese medicine thinks, the cause of disease of colorectal cancer body weakness, spleen kidney deficiency, dietary factor, the daily life several aspects such as depressed that do not save, are worried of being mainly always or usually as specified.Internal and external reasons combined effect is in human body, and impairing the spleen and stomach, causes the biochemical weary source of QI and blood, and healthy energy is deficient, and pathogen is taken advantage of and attacked, and pents up in large intestine, and mechanism of qi is obstructed, hematogenous blockage, and expectorant ecchymosis knot, forms tumor.Pathogenic characteristic is vital QI being weakened and pathogen being violent, and weakened body resistance is this, and the domination of pathogen is mark.Determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs is the key link of Chinese traditional treatment colorectal cancer, directly affects clinical efficacy.
Summary of the invention
For the defect existing in prior art, the object of the present invention is to provide a kind of Chinese medicine composition for the treatment of intestinal cancer.
Technical scheme of the present invention is as follows:
Treat a Chinese medicine composition for intestinal cancer, formed according to weight fraction by following component:
Calculus Equi 5-10 part, Herba Peristrophes 20-30 part, Caulis Sargentodoxae 20-30 part, Rhizoma Menispermi 20-30 part, Herba Saxifragae 20-30 part, Herba Solani Lyrati 20-30 part, Radix Tripterygii Wilfordii 10-20 part, Fructus Gardeniae 10-20 part, Rhizoma Arisaematis 10-20 part, Caulis Perillae 5-15 part, Radix Et Caulis Acanthopanacis Senticosi 5-15 part, Poria 5-15 part, 10 parts, Radix Glycyrrhizae.
On the basis of such scheme, a kind of Chinese medicine composition for the treatment of intestinal cancer, is made up of according to weight fraction following component:
8 parts of Calculus Equis, 25 parts of Herba Peristrophess, 25 parts of Caulis Sargentodoxae, 25 parts of Rhizoma Menispermis, 25 parts of Herba Saxifragaes, 25 parts of Herba Solani Lyratis, 15 parts of Radix Tripterygii Wilfordiis, 15 parts of Fructus Gardeniaes, 15 parts of Rhizoma Arisaematis, 10 parts of Caulis Perillaes, 10 parts of Radix Et Caulis Acanthopanacis Senticosis, 10 parts of Porias, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention, reasonable recipe, in prescription: Calculus Equi heat-clearing and toxic substances removing, the removing toxic substances of Herba Peristrophes dissipating blood stasis, Caulis Sargentodoxae heat-clearing and toxic substances removing, invigorate blood circulation, pain relieving, Rhizoma Menispermi heat-clearing and toxic substances removing, inducing diuresis and reducing edema, Herba Saxifragae heat clearing away, removing pathogenic heat from blood and toxic substance from the body, Herba Solani Lyrati heat-clearing and toxic substances removing, inducing diuresis and reducing edema, six medicines are monarch drug altogether; Radix Tripterygii Wilfordii reducing swelling and alleviating pain, promoting blood circulation to remove obstruction in the collateral, Fructus Gardeniae reducing swelling and alleviating pain, cooling blood for hemostasis, Rhizoma Arisaematis reducing swelling and alleviating pain, eliminating stagnation, three medicines are ministerial drug altogether; Caulis Perillae regulating the flow of QI to ease the stomach, Radix Et Caulis Acanthopanacis Senticosi replenishing QI to invigorate the spleen, Poria spleen invigorating, three medicines are adjuvant drug altogether; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, the mitigation property of medicine are for making medicine.
The Chinese medicine composition for the treatment of intestinal cancer of the present invention, formulated according to theory of Chinese medical science, each taste Chinese medicine composition, plays altogether heat clearing away, removing toxic substances, reducing swelling and alleviating pain, regulates the flow of vital energy, effect of spleen invigorating, Chinese medicine preparation, toxic and side effects is little, and cost is low, treating both the principal and secondary aspects of a disease.
The specific embodiment
Embodiment 1
Treat a Chinese medicine composition for intestinal cancer, form (every part of 1g) by following component according to weight fraction:
5 parts of Calculus Equis, 20 parts of Herba Peristrophess, 20 parts of Caulis Sargentodoxae, 20 parts of Rhizoma Menispermis, 20 parts of Herba Saxifragaes, 20 parts of Herba Solani Lyratis, 10 parts of Radix Tripterygii Wilfordiis, 10 parts of Fructus Gardeniaes, 10 parts of Rhizoma Arisaematis, 5 parts of Caulis Perillaes, 5 parts of Radix Et Caulis Acanthopanacis Senticosis, 5 parts of Porias, 10 parts, Radix Glycyrrhizae.
Concrete preparation method is as follows:
Take according to quantity above-mentioned composition, join in 1000 parts of water after other components except Calculus Equi are crushed to 100 orders, soak and decoct 30 minutes after 2 hours, filter, discard filtering residue, join in filtrate after Calculus Equi is crushed to 700 orders, before taking, mix.
Embodiment 2
Treat a Chinese medicine composition for intestinal cancer, form (every part of 1g) by following component according to weight fraction:
8 parts of Calculus Equis, 25 parts of Herba Peristrophess, 25 parts of Caulis Sargentodoxae, 25 parts of Rhizoma Menispermis, 25 parts of Herba Saxifragaes, 25 parts of Herba Solani Lyratis, 15 parts of Radix Tripterygii Wilfordiis, 15 parts of Fructus Gardeniaes, 15 parts of Rhizoma Arisaematis, 10 parts of Caulis Perillaes, 10 parts of Radix Et Caulis Acanthopanacis Senticosis, 10 parts of Porias, 10 parts, Radix Glycyrrhizae.
Concrete preparation method is as follows:
Take according to quantity above-mentioned composition, join in 1000 parts of water after other components except Calculus Equi are crushed to 100 orders, soak and decoct 30 minutes after 2 hours, filter, discard filtering residue, join in filtrate after Calculus Equi is crushed to 700 orders, before taking, mix.
Embodiment 3
Treat a Chinese medicine composition for intestinal cancer, form (every part of 1g) by following component according to weight fraction:
10 parts of Calculus Equis, 30 parts of Herba Peristrophess, 30 parts of Caulis Sargentodoxae, 30 parts of Rhizoma Menispermis, 30 parts of Herba Saxifragaes, 30 parts of Herba Solani Lyratis, Radix Tripterygii Wilfordii 10-20 part, 20 parts of Fructus Gardeniaes, 20 parts of Rhizoma Arisaematis, 15 parts of Caulis Perillaes, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 15 parts of Porias, 10 parts, Radix Glycyrrhizae.
Concrete preparation method is as follows:
Take according to quantity above-mentioned composition, join in 1000 parts of water after other components except Calculus Equi are crushed to 100 orders, soak and decoct 30 minutes after 2 hours, filter, discard filtering residue, join in filtrate after Calculus Equi is crushed to 700 orders, before taking, mix.
Experimental example:
1) basic document
Choose the court's data patients with bowel cancer 150 examples completely, the age is that between 35-68 year, the mean age is 48.5 years old, and wherein, male patient is 88 examples, and female patient is 62 examples.
2) intestinal cancer efficacy evaluation:
Cure: transference cure, checks that cancerous cell disappears.
Take a turn for the better: symptom alleviates, cancerous cell reduces.
Do not heal: symptom is unchanged, cancerous cell continues diffusion.
3) Therapeutic Method
Take medicine prepared by embodiment 2 methods, potion, divided and took for three times every day, and each 300ml(need rock medicinal liquid while taking, to guarantee that Calculus Equi powder is dispersed in medicinal liquid), within 30 days, be a course for the treatment of, take continuously 6 courses for the treatment of
4) therapeutic outcome
Drug therapy patients with bowel cancer 150 examples of the present invention, cure 47 examples, 58 examples that take a turn for the better, and 45 examples that do not heal, effective percentage reaches 70%.
Case 1:
In certain, female, 40 years old, Wang Ge people from village, Qingdao, within 2008, hospital is diagnosed as 0 phase of intestinal cancer, treats through many places, and carry out chemotherapy radiotherapy, and having no and alleviate, side effect is large, can not proceed treatment, Chinese traditional treatment was selected in here afterwards, took 2 courses for the treatment of of medicine prepared by embodiment 1 method, and symptom alleviates, after continuing to take 4 courses for the treatment of, transference cure is cured through examination in hospital, and rear return visit is not recurred.
Case 2:
Wu, man, 56 years old, people from Zhucheng, within 2008, hospital is diagnosed as the intestinal cancer I phase, is in hospital and has no obvious improvement half a year, and treated in here afterwards, takes 3 courses for the treatment of of medicine prepared by embodiment 3 methods, symptom alleviates, continue to take 3 courses for the treatment of after transference cure cure through examination in hospital, rear return visit is not recurred.
Case 3:
Ancestral, man, 51 years old, people from Binzhou, within 2009, hospital is diagnosed as the intestinal cancer II phase, through many hospitalize DeGrains, be reluctant to undergo surgery, carry out after being introduced here treatment, developed into the III phase, take 4 courses for the treatment of of medicine prepared by embodiment 2 methods, symptom alleviates, continue to take after 2 courses for the treatment of, not controlled in the diffusion state of an illness through examination in hospital cancerous cell, now hold on and take medicine.
Claims (2)
1. treat a Chinese medicine composition for intestinal cancer, it is characterized in that being formed according to weight fraction by following component:
Calculus Equi 5-10 part, Herba Peristrophes 20-30 part, Caulis Sargentodoxae 20-30 part, Rhizoma Menispermi 20-30 part, Herba Saxifragae 20-30 part, Herba Solani Lyrati 20-30 part, Radix Tripterygii Wilfordii 10-20 part, Fructus Gardeniae 10-20 part, Rhizoma Arisaematis 10-20 part, Caulis Perillae 5-15 part, Radix Et Caulis Acanthopanacis Senticosi 5-15 part, Poria 5-15 part, 10 parts, Radix Glycyrrhizae.
2. the Chinese medicine composition for the treatment of intestinal cancer according to claim 1, is characterized in that being made up of according to weight fraction following component:
8 parts of Calculus Equis, 25 parts of Herba Peristrophess, 25 parts of Caulis Sargentodoxae, 25 parts of Rhizoma Menispermis, 25 parts of Herba Saxifragaes, 25 parts of Herba Solani Lyratis, 15 parts of Radix Tripterygii Wilfordiis, 15 parts of Fructus Gardeniaes, 15 parts of Rhizoma Arisaematis, 10 parts of Caulis Perillaes, 10 parts of Radix Et Caulis Acanthopanacis Senticosis, 10 parts of Porias, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410012560.9A CN103768300A (en) | 2014-01-13 | 2014-01-13 | Traditional Chinese medicinal composition for treating intestinal cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410012560.9A CN103768300A (en) | 2014-01-13 | 2014-01-13 | Traditional Chinese medicinal composition for treating intestinal cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103768300A true CN103768300A (en) | 2014-05-07 |
Family
ID=50561360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410012560.9A Pending CN103768300A (en) | 2014-01-13 | 2014-01-13 | Traditional Chinese medicinal composition for treating intestinal cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103768300A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1171254A (en) * | 1996-07-18 | 1998-01-28 | 宗金 | Oral liquid for treating lung cancer and intestinal cancer and preparing process thereof |
CN1739783A (en) * | 2005-09-16 | 2006-03-01 | 王俊 | Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer |
CN101181609A (en) * | 2007-11-08 | 2008-05-21 | 李祖科 | Externally used antitumor chinese herbal medicine |
WO2013126368A1 (en) * | 2012-02-20 | 2013-08-29 | The General Hospital Corporation | Methods, assays, and systems relating to sakt |
-
2014
- 2014-01-13 CN CN201410012560.9A patent/CN103768300A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1171254A (en) * | 1996-07-18 | 1998-01-28 | 宗金 | Oral liquid for treating lung cancer and intestinal cancer and preparing process thereof |
CN1739783A (en) * | 2005-09-16 | 2006-03-01 | 王俊 | Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer |
CN101181609A (en) * | 2007-11-08 | 2008-05-21 | 李祖科 | Externally used antitumor chinese herbal medicine |
WO2013126368A1 (en) * | 2012-02-20 | 2013-08-29 | The General Hospital Corporation | Methods, assays, and systems relating to sakt |
Non-Patent Citations (3)
Title |
---|
RENATA FERRAROTTO,等。: ""Antiangiogenic Drugs for Colorectal Cancer:Exploring New Possibilities"", 《CLINICAL COLORECTAL CANCER》 * |
刘静,等。: ""中医药治疗大肠癌辨证用药分析"", 《辽宁中医杂志》 * |
李灵常,等。: ""大肠癌的中医药实验研究进展"", 《中华中医药学刊》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150374778A1 (en) | Pharmaceutical composition for treating cancers and preparation method therefor | |
CN104523865B (en) | Medicine for treating breast diseases | |
CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
CN101972424B (en) | Traditional Chinese medicine for treating cirrhosis ascites | |
CN103520461A (en) | Medicine for treating allergic rhinitis | |
CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
CN109125559B (en) | Traditional Chinese medicine for treating qi-yin deficiency syndrome of purpuric nephritis in children | |
CN103432501B (en) | A kind of preparation method of the Chinese medicine composition and preparation thereof for treating chronic colitis | |
CN101327293B (en) | Capsules for treating peptic ulcer and preparation method thereof | |
CN102641471A (en) | Traditional Chinese medicine for treating cholelithiasis | |
CN103230518B (en) | Traditional Chinese medical composition for treating peptic ulcer | |
CN106039237A (en) | Traditional Chinese medicinal formula for treating nephrolithiasis | |
CN103768300A (en) | Traditional Chinese medicinal composition for treating intestinal cancer | |
CN104784559A (en) | Traditional Chinese medicine preparation for treating postcholecystectomy syndrome | |
CN104771516A (en) | Traditional Chinese medicine composition for treating allergic dermatitis | |
CN103520591B (en) | Chinese medicine for chronic urticaria | |
CN103550690A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
CN103768214B (en) | A kind of Chinese medicine composition for the treatment of kidney yang deficiency syndrome rhinitis | |
CN101940709B (en) | Traditional Chinese medicine for treating epigastric pain | |
CN101954018A (en) | Oral medicament for treating chronic nephritis | |
CN101264268B (en) | Proprietary Chinese medicine for treating tumor | |
CN105125949A (en) | Chinese drug preparation for treating syndromes after cholecystotomy | |
CN106668760A (en) | Formula of traditional Chinese medicine for treating kidney calculi | |
CN105477067A (en) | Traditional Chinese medicine composition for treating dampness obstructing spleen-stomach type infantile jaundice | |
Seo et al. | Repeated Postoperative Adhesive Small Bowel Obstruction Treated with Daeseunggi-tang and Acupuncture Treatment in Elderly: A Case Report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140507 |